Ignite Creation Date:
2025-12-24 @ 11:52 PM
Ignite Modification Date:
2025-12-25 @ 9:47 PM
Study NCT ID:
NCT00754351
Status:
COMPLETED
Last Update Posted:
2012-06-28
First Post:
2008-09-17
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Docetaxel, Gemcitabine and Bevacizumab for Metastatic Breast Cancer
Sponsor:
University Hospital of Crete
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2008-09
Start Date Type:
None
Primary Completion Date:
2012-02
Primary Completion Date Type:
ACTUAL
Completion Date:
2012-02
Completion Date Type:
ACTUAL
First Submit Date:
2008-09-17
First Submit QC Date:
None
Study First Post Date:
2008-09-18
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2012-06-26
Last Update Post Date:
2012-06-28
Last Update Post Date Type:
ESTIMATED